[Effects of T-activin in viral myocarditis in animal experiments].
The efficacy of immunomodulating agent T-activin has been studied in adult BALB/C mice infected with Coxsackie B1 virus. Optical, electron microscopic and immunological tests have shown that T-activin protects myocardium and modulates immune disorders in mice with viral myocarditis.
Kipshidze
N N
NN
Dzhaparidze
M M
MM
Bulusashvili
R V
RV
Khuchua
A V
AV
Zbiadadze
N A
NA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D003384:Coxsackievirus Infections / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D005260:Female; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009205:Myocarditis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D013949:Thymus Extracts / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Vliianie T-aktivina na virusnyĭ miokardit v éksperimente.